Andrew Saik Vyne Therapeutics Inc. (VYNE) insider trading activity

VYNE Quotes by TradingView

Andrew Saik is Chief Financial Officer of VYNE Therapeutics Inc.. Currently has a direct ownership of 116,468 shares of VYNE, which is worth approximately $358,721. The most recent transaction as insider was on May 28, 2021, when has been sold 3,017 shares (Common Stock) at a price of $3.36 per share, resulting in proceeds of $10,137. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
0% 3M change
0% 12M change
Total Value Held $358,721

Andrew Saik Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 28 2021
BUY
Grant, award, or other acquisition
$10,137 $3.36 p/Share
3,017 Added 2.53%
116,468 Common Stock
Mar 31 2021
SELL
Payment of exercise price or tax liability
$5,212 $6.84 p/Share
762 Reduced 0.67%
113,451 Common Stock
Feb 22 2021
BUY
Grant, award, or other acquisition
-
29,213 Added 20.37%
114,213 Common Stock

Also insider at

ICPT
INTERCEPT PHARMACEUTICALS, INC. Healthcare
EVP & Chief Financial Officer
ARVN
ARVINAS, INC. Healthcare
Chief Financial Officer
MIST
Milestone Pharmaceuticals Inc. Healthcare
AS

Andrew Saik

Chief Financial Officer
Morristown, NJ

Track Institutional and Insider Activities on VYNE

Follow VYNE Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYNE shares.

Notify only if

Insider Trading

Get notified when an Vyne Therapeutics Inc. insider buys or sells VYNE shares.

Notify only if

News

Receive news related to VYNE Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VYNE